217 related articles for article (PubMed ID: 9306941)
1. Flow cytometric DNA hypertetraploidy is associated with unfavourable prognostic features in breast cancer.
Pinto AE; André S; Nogueira M; Mendonça E; Soares J
J Clin Pathol; 1997 Jul; 50(7):591-5. PubMed ID: 9306941
[TBL] [Abstract][Full Text] [Related]
2. Short-term significance of DNA ploidy and cell proliferation in breast carcinoma: a multivariate analysis of prognostic markers in a series of 308 patients.
Pinto AE; André S; Soares J
J Clin Pathol; 1999 Aug; 52(8):604-11. PubMed ID: 10645231
[TBL] [Abstract][Full Text] [Related]
3. Flow cytometric DNA hypertetraploidy tends to be more frequent in male than in female breast cancers.
Bezić J; Šamija Projić I; Projić P; Ljubković J; Zekić Tomaš S; Meljanac Salopek K; Piljić Burazer M; Tomić S
Virchows Arch; 2015 Feb; 466(2):185-9. PubMed ID: 25471639
[TBL] [Abstract][Full Text] [Related]
4. Flow cytometric DNA analysis as prognostic factor in human breast carcinoma.
Ottestad L; Pettersen EO; Nesland JM; Hannisdal E; Fosså SD; Tveit KM
Pathol Res Pract; 1993 May; 189(4):405-10. PubMed ID: 8351241
[TBL] [Abstract][Full Text] [Related]
5. Chromatin texture, DNA index, and S-phase fraction in primary breast carcinoma cells analysed by laserscanning cytometry.
Kuliffay P; Sanislo L; Galbavy S
Bratisl Lek Listy; 2010; 111(1):4-8. PubMed ID: 20429304
[TBL] [Abstract][Full Text] [Related]
6. Prognostic indicators including DNA histogram type, receptor content, and staging related to human breast cancer patient survival.
Coulson PB; Thornthwaite JT; Woolley TW; Sugarbaker EV; Seckinger D
Cancer Res; 1984 Sep; 44(9):4187-96. PubMed ID: 6744328
[TBL] [Abstract][Full Text] [Related]
7. DNA ploidy is an independent predictor of survival in breast invasive ductal carcinoma: a long-term multivariate analysis of 393 patients.
Pinto AE; Pereira T; Santos M; Branco M; Dias A; Silva GL; Ferreira MC; André S
Ann Surg Oncol; 2013 May; 20(5):1530-7. PubMed ID: 23250736
[TBL] [Abstract][Full Text] [Related]
8. [DNA ploidy is an independent prognostic biomarker in breast invasive ductal carcinoma].
Pinto AE; Pereira T; Silva GL; Ferreira MC; André S
Acta Med Port; 2012; 25(6):399-407. PubMed ID: 23534591
[TBL] [Abstract][Full Text] [Related]
9. Tumour DNA ploidy as an independent prognostic factor in breast cancer.
Kallioniemi OP; Blanco G; Alavaikko M; Hietanen T; Mattila J; Lauslahti K; Koivula T
Br J Cancer; 1987 Nov; 56(5):637-42. PubMed ID: 3426929
[TBL] [Abstract][Full Text] [Related]
10. Can we identify the group of small invasive (T1a,b) breast cancers with minimal risk of axillary lymph node involvement? A pathohistological and DNA flow cytometric study.
Bezić J; Samija-Projić I; Projić P; Ljubković J; Capkun V; Tomić S
Pathol Res Pract; 2011 Jul; 207(7):438-42. PubMed ID: 21689895
[TBL] [Abstract][Full Text] [Related]
11. Cytometric DNA analysis and prognostic biomarkers in breast carcinoma. Expression of P53 product in the different ploidy classes.
Leonardi E; Cristofori A; Caffo O; Dalla Palma P
Anal Cell Pathol; 1997; 15(1):31-45. PubMed ID: 9373711
[TBL] [Abstract][Full Text] [Related]
12. Coordinated expression of ER, PR and HER2 define different prognostic subtypes among poorly differentiated breast carcinomas.
Fernandes RC; Bevilacqua JL; Soares IC; Siqueira SA; Pires L; Hegg R; Carvalho FM
Histopathology; 2009 Sep; 55(3):346-52. PubMed ID: 19723150
[TBL] [Abstract][Full Text] [Related]
13. Global DNA hypomethylation in breast carcinoma: correlation with prognostic factors and tumor progression.
Soares J; Pinto AE; Cunha CV; André S; Barão I; Sousa JM; Cravo M
Cancer; 1999 Jan; 85(1):112-8. PubMed ID: 9921982
[TBL] [Abstract][Full Text] [Related]
14. Relationship between DNA ploidy and survival in patients with primary breast cancer.
Eskelinen MJ; Pajarinen P; Collan Y; Pesonen E; Alhava E; Kettunen K; Nordling S
Br J Surg; 1989 Aug; 76(8):830-4. PubMed ID: 2765840
[TBL] [Abstract][Full Text] [Related]
15. In lymph node-negative invasive breast carcinomas, specific chromosomal aberrations are strongly associated with high mitotic activity and predict outcome more accurately than grade, tumour diameter, and oestrogen receptor.
Janssen EA; Baak JP; Guervós MA; van Diest PJ; Jiwa M; Hermsen MA
J Pathol; 2003 Dec; 201(4):555-61. PubMed ID: 14648658
[TBL] [Abstract][Full Text] [Related]
16. Static and flow cytometric DNA analysis compared to histologic prognostic factors in a cohort of stage T2 breast cancer.
Arnerlöv C; Emdin SO; Roos G; Angström T; Bjersing L; Angquist KA; Jonsson H
Eur J Surg Oncol; 1990 Jun; 16(3):200-8. PubMed ID: 2347415
[TBL] [Abstract][Full Text] [Related]
17. Flow cytometric DNA index and S-phase fraction in breast cancer in relation to other prognostic variables and to clinical outcome.
Fernö M; Baldetorp B; Borg A; Olsson H; Sigurdsson H; Killander D
Acta Oncol; 1992; 31(2):157-65. PubMed ID: 1622630
[TBL] [Abstract][Full Text] [Related]
18. Mutant p53 expression and DNA analysis in human breast cancer comparison with conventional clinicopathological parameters.
Rosanelli GP; Steindorfer P; Wirnsberger GH; Klimpfinger M; Ratschek M; Puerstner P; Auner H; Berhold A
Anticancer Res; 1995; 15(2):581-6. PubMed ID: 7763041
[TBL] [Abstract][Full Text] [Related]
19. Correlation between p53, c-erbB-2, and topoisomerase II alpha expression, DNA ploidy, hormonal receptor status and proliferation in 356 node-negative breast carcinomas: prognostic implications.
Rudolph P; Olsson H; Bonatz G; Ratjen V; Bolte H; Baldetorp B; Fernö M; Parwaresch R; Alm P
J Pathol; 1999 Jan; 187(2):207-16. PubMed ID: 10365096
[TBL] [Abstract][Full Text] [Related]
20. Independent prognostic value of hormone receptor expression and S-phase fraction in advanced breast cancer.
Pinto AE; Mendonça E; André S; Nóbrega SD; Soares J
Anal Quant Cytol Histol; 2002 Dec; 24(6):345-54. PubMed ID: 12508694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
